SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported)   July 2, 1999
                                                 -----------------


                                 ConSyGen, Inc.
                                 --------------
               (Exact Name of Registrant as Specified in Charter)


            Texas                     17598                       76-0260145
- ----------------------------      ------------               -------------------
(State or Other Jurisdiction      (Commission                  (IRS Employer
     of Incorporation)            File Number)               Identification No.)


  125 South 52nd Street, Tempe Arizona                              85281
- ----------------------------------------                     -------------------
(Address of Principal Executive Offices)                          (Zip Code)


Registrant's telephone number, including area code  (602) 394-9100
                                                    --------------
                                      N/A
         ------------------------------------------------------------
         (Former Name or Former Address, if Changed Since Last Report)

ITEM 2. ACQUISITION OF ASSET

On June 16, 1999, the registrant entered into an agreement with F&M Investments,
L.L.C.,  of  Atlanta,  Georgia,  pursuant  to which the  registrant  purchased a
certain  computer  software  program.  The  software  has never been applied for
commercial purposes. The registrant expects to use it to generate other software
programs  for  use by  prospective  customers  in  Internet  commerce,  Personal
Computer Software and Corporate  Computing.  It is estimated by management that,
in addition to the purchase price set forth below,  further  development of that
software,  the  development  of derivative  programs and initial  marketing will
require the expenditure of approximately $875,000. The software has not yet been
put to use by the  registrant  and there is no assurance  that the  registrant's
expectations will be met.

The purchase  price is  $600,000,  payable in three  non-refundable  deposits of
$60,000 each and a final payment of $420,000. The first $60,000 payment was made
on June 18,  1999,  the  second  such  payment is due  within 10  business  days
thereafter  and the third such  payment is due within the  following 10 business
days and the final  payment of $420,000 is due ten business days after the third
$60,000 payment.

Prior to making the first  payment,  the  registrant  evaluated the software and
deemed it acceptable.

The  effective  date of the  agreement  will be the date upon which all payments
have been made.  Title to the software  will pass to the  registrant if and when
full  payment  has been made.  The seller  will  deliver  the  following  to the
registrant within five days after the said effective date:

(1) a master copy of the software program (in both source and object form), in a
form suitable for copying,  (2) all system and user  documentation,  and (3) all
marketing and  market-related  information,  if any,  pertaining to the software
program.


ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS

(c)  Exhibits.  The  following  exhibit  is  required  pursuant  to Item  601 of
Regulation S-K:

4.13  Agreement  entitled, "Transfer  of  complete  rights in  Software  program
      Between ConSyGen, Inc. and F&M Investments, L.L.C.

                                    SIGNATURES


         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                     ConSyGen, Inc.

Date: July 2, 1999                   By:  /s/ A. Lewis Burridge
      ----------------                   -------------------------------------
                                              A. Lewis Burridge, President
                                              and Chief Executive Officer